Quick Answer
BioRestorative Therapies, Inc. reported Total Revenue of $359.7 thousand for the year ending 2025.
- BioRestorative Therapies, Inc. showed a decrease of -10.3% in Total Revenue from 2024 to 2025.
- This data is from BioRestorative Therapies, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2011 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $375.00 | Q2 2014: $175.9 thousand | Q3 2014: $159.9 thousand | Q1 2015: $184.9 thousand | Q2 2015: $148.8 thousand | Q3 2015: $96.1 thousand | Q1 2016: $9.1 thousand | Q2 2016: $16.2 thousand | Q3 2016: $5.0 thousand | Q1 2017: $7.0 thousand | Q2 2017: $20.0 thousand | Q3 2017: $16.0 thousand | Q1 2018: $19.0 thousand | Q1 2018: $19.0 thousand | Q2 2018: $37.0 thousand | Q2 2018: $37.0 thousand | Q3 2018: $26.0 thousand | Q3 2018: $26.0 thousand | Q1 2019: $29.0 thousand | Q2 2019: $31.0 thousand | Q3 2019: $38.0 thousand | Q1 2020: $26.0 thousand | Q2 2020: $19.0 thousand | Q3 2020: $15.0 thousand | Q1 2021: $18.0 thousand | Q2 2021: $15.0 thousand | Q3 2021: $8.0 thousand | Q1 2022: $16.0 thousand | Q2 2022: $71.1 thousand | Q3 2022: $29.0 thousand | Q1 2023: $31.3 thousand | Q2 2023: $64.5 thousand | Q3 2023: $30.7 thousand | Q1 2024: $35.0 thousand | Q2 2024: $89.1 thousand | Q3 2024: $233.6 thousand | Q1 2025: $25.0 thousand | Q2 2025: $303.3 thousand | Q3 2025: $11.8 thousand.
- Historical annual values: Fiscal year 2025: $359.7 thousand | Fiscal year 2024: $401.0 thousand | Fiscal year 2023: $145.8 thousand | Fiscal year 2022: $119.8 thousand | Fiscal year 2021: $46.0 thousand | Fiscal year 2020: $77.0 thousand | Fiscal year 2019: $130.0 thousand | Fiscal year 2018: $111.0 thousand | Fiscal year 2017: $81.0 thousand | Fiscal year 2017: $81.0 thousand | Fiscal year 2016: $36.4 thousand | Fiscal year 2015: $628.9 thousand | Fiscal year 2014: $416.0 thousand | Fiscal year 2013: $1.7 thousand | Fiscal year 2012: $15.6 thousand | Fiscal year 2011: $0.00.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: